Related Experiment Video
Updated: Jul 3, 2026

04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Persistent interface fluid syndrome
Richard S Hoffman1, I Howard Fine, Mark Packer
1Hoffman & Packer LLC, Eugene, OR 97403, USA. rshoffman@finemd.com <rshoffman@finemd.com>
Journal of Cataract and Refractive Surgery
|July 29, 2008
Summary
Persistent interface fluid after corneal transplant was resolved by repositioning the laser in situ keratomileusis flap. Scarring at the graft-host margin may have caused this intractable fluid, requiring surgical intervention.
Area of Science:
- Ophthalmology
- Corneal Surgery
- Interface Fluid Management
Background:
- Persistent interface fluid is a rare complication following corneal transplantation.
- Descemet-stripping endothelial keratoplasty (DSEK) is a common procedure for corneal endothelial dysfunction.
- Standard management often fails to resolve persistent interface fluid.
Observation:
- A case of intractable interface fluid is presented.
- The fluid persisted despite normal intraocular pressure.
- Corneal endothelial replacement with DSEK did not resolve the fluid.
Findings:
- Surgical intervention involving dissection, elevation, and repositioning of the laser in situ keratomileusis (LASIK) flap was necessary.
- This intervention successfully resolved the persistent interface fluid.
- Circumferential corneal graft-host margin scar formation was hypothesized as the cause.
Implications:
- This case highlights a potential cause of intractable interface fluid after corneal surgery.
- Repositioning of a LASIK flap may be a viable treatment option in refractory cases.
- Understanding scar formation mechanics is crucial for managing post-keratoplasty fluid accumulation.
More Related Videos
Related Concept Videos
Ascites
DefinitionAscites is the buildup of fluid inside the peritoneal cavity. It occurs when fluid moves out of the vascular system faster than the peritoneal lymphatics can remove it. This fluid shift is most commonly seen in liver cirrhosis but can also appear in several other systemic disorders.EtiologyCirrhosis remains the leading cause of ascites. Other conditions that can contribute include:Heart failureConstrictive pericarditisAbdominal cancersNephrotic syndromeSevere protein–calorie...
Diabetes Insipidus I: Introduction
Definition Diabetes insipidus is a disorder marked by the production of large amounts of dilute urine because of impaired vasopressin production, release, or kidney response. The lack of effective vasopressin action limits water reabsorption in the renal collecting ducts, which leads to excessive urinary water loss and intense thirst.Clinical PresentationIndividuals with diabetes insipidus report persistent thirst and very high urine output. In severe cases, fluid intake can reach up to 20...
Pleural Effusion I: Introduction
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Irritable Bowel Syndrome
DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...
Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...

